Tonometer disinfection failure puts patients at risk

Article

Many UK institutions are not compliant with current international guidelines on tonometer disinfection, according to a study published in the August 2008 issue of Eye.

Many UK institutions are not compliant with current international guidelines on tonometer disinfection, according to a study published in the August 2008 issue of Eye.

Roxane J. Hillier, MRCOphtha of Manchester Royal Eye Hospital, UK and colleagues conducted a telephone questionnaire of a senior nurse at every ophthalmology unit with training recognition in the UK (n=155) to compare current tonometer disinfection practice with published guidelines. Of the respondents, 23% (n=35) were excluded immediately as they reported that they used only disposable tonometer heads. The remaining 77% (n=120) used either reusable or a combination of reusable and disposable heads.

A chlorine-based solution was used to disinfect 67% of units (n=80). The concentration of chlorine used ranged from 125 to 30000 ppm, although 63% of units (n=50) used a concentration of <5000 ppm, which is the strength of disinfection recommended in published guidelines. Other disinfectant solutions used included: isopropyl alcohol (n=18), hydrogen peroxide (n=12), chloramine (n=5), chlorhexidine (n=4) and peracetic acid (n=1). One tonometer head per practitioner was provided in 29% of units (n=29); it is likely that these practitioners do not have sufficient time to disinfect these heads between patients. All units questioned replenished disinfectant daily, which is adequate for all solutions except hydrogen peroxide: of the 12 units using this disinfectant, 75% (n=9) did not replenish the solution (as required) twice daily.

The researchers concluded that, although the disinfection practices vary quite widely across the country, most units in the UK do not meet internationally recommended health and safety guidelines on tonometer head disinfection, leaving patients vulnerable to the risk of infection.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
© 2025 MJH Life Sciences

All rights reserved.